EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Natural cycle versus hormone replacement therapy as endometrial preparation in ovulatory women undergoing frozen-thawed embryo transfer: The COMPETE open-label randomized controlled trial

Xitong Liu iD, Wentao Li iD, Wen Wen, Ting Wang, Tao Wang, Ting Sun, Na Zhang, Dan Pan, Jinlin Xie, Xiaojuan Liu, He Cai, Xiaofang Li und 16 weitere

PLOS Medicine · 25.06.2025 · 22 (6) · e1004630

DOI: 10.1371/journal.pmed.1004630 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS Medicine, online erschienen am 25.06.2025. Verfasst von Xitong Liu und 27 weiteren Autor:innen. Beteiligte Einrichtung: The Assisted Reproduction Center, Northwest Women's and Children's Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Embryo Transfer, Endometrium, Hormone Replacement Therapy, Ovulation. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Clinical Specialty Construction Project, Key Research and Development Projects of Shaanxi Province, the General Projects of Social Development in Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Different endometrial preparation protocols are used prior to frozen-thawed embryo transfer (FET). Optimization of endometrial preparation protocols is mandatory to improve live birth rate and obstetric and perinatal outcomes. In the Comparison of Endometrial Preparation Protocols for Frozen Embryo Transfer (COMPETE) trial, our primary objective is to evaluate whether natural cycles (NCs) lead to a higher live birth rate after the first FET cycle compared to hormone replacement therapy (HRT) cycles in women with a regular ovulatory cycle. Methods and findings We performed a single-center, parallel, open-label randomized controlled trial between December 2020 and December 2022 in a single assisted reproduction center in Xi’an, China. Women with a regular menstrual cycle undergoing in vitro fertilization (IVF) scheduled for FET were randomly assigned (1:1) to endometrial preparation in the NC or with HRT, using a web-based electronic data capture system. The primary outcome was live birth rate after the initial FET. The analysis was conducted based on the intention-to-treat principle. Obstetric and perinatal outcomes in all randomly assigned women were reported in this study. We randomly assigned 902 women to receive either NC ( n = 448) or HRT ( n = 454). In the NC group, 101 women received HRT because of no ovulation, while in the HRT group, 29 women received NC because of spontaneous ovulation. The number of live births was 242 (54.0%) in the NC group versus 195 (43.0%) in the HRT group (absolute difference, 11.1 percentage points, 95% CI 4.6 to 17.5; risk ratio (RR) 1.26, 95% CI 1.10 to 1.44). Miscarriage rates (RR 0.61, 95% CI 0.41 to 0.89) and the antepartum hemorrhage rates (RR 0.63, 95%CI 0.42 to 0.93) were lower in the NC group, with other obstetric and perinatal outcomes not significantly different.

Conclusions

In women with a regular menstrual cycle undergoing FET, a strategy starting with NC endometrial preparation results in higher live birth rates than endometrial preparation with HRT. However, the permitted cross-over between arms limits certainty in directly assessing NC versus HRT efficacy.

Trial registration

Chinese Clinical Trial Registry: ChiCTR2000040640.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embryo TransferEndometriumHormone Replacement TherapyOvulationMenstrual CycleHumansFemaleAdultPregnancyCryopreservationLive BirthFertilization in VitroPregnancy RateChinaBirth Rate

Autor:innen und Institutionen

  • The Assisted Reproduction Center, Northwest Women's and Children's Hospital, Xi'an, China.
  • National Perinatal Epidemiology and Statistics Unit, Centre for Big Data Research in Health and School of Women's and Children's Health, The University of New South Wales, Sydney, Australia.
  • Graduate Department, Xi'an Medical University, Xi'an, China.
  • Translational Medicine Center, Northwest Women's and Children's Hospital, Xi'an, China.
  • Department of Obstetrics and Gynaecology, Monash University, Monash Medical Centre, Wellington Road, Clayton, Victoria, Australia.
  • Department of Obstetrics and Gynaecology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.

ORCID-Profile: Xitong Liu, Wentao Li, Ben W Mol, Juanzi Shi

Förderung

  • National Key Clinical Specialty Construction Project
  • Key Research and Development Projects of Shaanxi Province
  • the General Projects of Social Development in Shaanxi Province
  • the Xi’an Municipal Science and Technology Bureau

Zitieren

APA

Liu, X., Li, W., Wen, W., Wang, T., Wang, T., Sun, T., Zhang, N., Pan, D., Xie, J., Liu, X., Cai, H., Li, X., Shi, Z., Wang, R., Lu, N., Bai, H., Pan, R., Tian, L., Meng, B., …, & Shi, J. (2025). Natural cycle versus hormone replacement therapy as endometrial preparation in ovulatory women undergoing frozen-thawed embryo transfer: The COMPETE open-label randomized controlled trial. PLOS Medicine, 22(6), e1004630. https://doi.org/10.1371/journal.pmed.1004630

Vancouver

Liu X, Li W, Wen W, Wang T, Wang T, Sun T, et al. Natural cycle versus hormone replacement therapy as endometrial preparation in ovulatory women undergoing frozen-thawed embryo transfer: The COMPETE open-label randomized controlled trial. PLOS Medicine. 2025;22(6):e1004630. doi:10.1371/journal.pmed.1004630

BibTeX
@article{Liu2025,
  author = {Liu, Xitong and Li, Wentao and Wen, Wen and Wang, Ting and Wang, Tao and Sun, Ting and Zhang, Na and Pan, Dan and Xie, Jinlin and Liu, Xiaojuan and Cai, He and Li, Xiaofang and Shi, Zan and Wang, Rui and Lu, Na and Bai, Haiyan and Pan, Rong and Tian, Li and Meng, Bin and Mu, Xin and Jia, Hongran and Zhou, Hanying and Cao, Xu and Liu, Tianxing and Qu, Pengfei and Liu, Danmeng and Mol, Ben W and Shi, Juanzi},
  title = {Natural cycle versus hormone replacement therapy as endometrial preparation in ovulatory women undergoing frozen-thawed embryo transfer: The COMPETE open-label randomized controlled trial},
  journal = {PLOS Medicine},
  year = {2025},
  volume = {22},
  number = {6},
  pages = {e1004630},
  doi = {10.1371/journal.pmed.1004630}
}
Kostenlos starten →